FR2899464B1 - C-GLYCOSIDE COMPOUND AND USE AS AN ACTIVATOR AND REGULATOR OF CUTANEOUS IMMUNITY - Google Patents

C-GLYCOSIDE COMPOUND AND USE AS AN ACTIVATOR AND REGULATOR OF CUTANEOUS IMMUNITY

Info

Publication number
FR2899464B1
FR2899464B1 FR0651255A FR0651255A FR2899464B1 FR 2899464 B1 FR2899464 B1 FR 2899464B1 FR 0651255 A FR0651255 A FR 0651255A FR 0651255 A FR0651255 A FR 0651255A FR 2899464 B1 FR2899464 B1 FR 2899464B1
Authority
FR
France
Prior art keywords
activator
regulator
glycoside compound
cutaneous immunity
cutaneous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0651255A
Other languages
French (fr)
Other versions
FR2899464A1 (en
Inventor
Alexandre Cavezza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0651255A priority Critical patent/FR2899464B1/en
Publication of FR2899464A1 publication Critical patent/FR2899464A1/en
Application granted granted Critical
Publication of FR2899464B1 publication Critical patent/FR2899464B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
FR0651255A 2006-04-07 2006-04-07 C-GLYCOSIDE COMPOUND AND USE AS AN ACTIVATOR AND REGULATOR OF CUTANEOUS IMMUNITY Expired - Fee Related FR2899464B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0651255A FR2899464B1 (en) 2006-04-07 2006-04-07 C-GLYCOSIDE COMPOUND AND USE AS AN ACTIVATOR AND REGULATOR OF CUTANEOUS IMMUNITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0651255A FR2899464B1 (en) 2006-04-07 2006-04-07 C-GLYCOSIDE COMPOUND AND USE AS AN ACTIVATOR AND REGULATOR OF CUTANEOUS IMMUNITY

Publications (2)

Publication Number Publication Date
FR2899464A1 FR2899464A1 (en) 2007-10-12
FR2899464B1 true FR2899464B1 (en) 2008-06-06

Family

ID=37461575

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0651255A Expired - Fee Related FR2899464B1 (en) 2006-04-07 2006-04-07 C-GLYCOSIDE COMPOUND AND USE AS AN ACTIVATOR AND REGULATOR OF CUTANEOUS IMMUNITY

Country Status (1)

Country Link
FR (1) FR2899464B1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100528128C (en) 2004-03-08 2009-08-19 荷兰联合利华有限公司 Hair treatment composition comprising sugar lactone
EP2120857B1 (en) 2007-03-14 2010-10-20 Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House Method of treating hair with a sugar composition
WO2008149022A2 (en) * 2007-05-18 2008-12-11 L'oreal Use of gem-difluorinated c-glycopeptides for promoting the pigmentation of keratinic materials
ATE518519T1 (en) 2007-10-10 2011-08-15 Unilever Nv HAIR TREATMENT METHOD
EP2259767B1 (en) 2008-03-28 2014-07-30 Unilever Plc Hair styling composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614615A (en) * 1995-03-21 1997-03-25 The Scripps Research Institute Sialyl Lewis X mimetics incorporating fucopeptides
FR2750864B1 (en) * 1996-07-10 1999-04-16 Oreal USE OF A POLYHOLOSIDE IN A COMPOSITION FOR STIMULATING IMMUNE DEFENSES, AND COMPOSITION COMPRISING SAME
FR2770776B1 (en) * 1997-11-07 2000-03-17 Lvmh Rech USES OF D-XYLOSE AND ITS ESTERS TO IMPROVE THE FUNCTIONALITY OF SKIN CELLS
FR2818646B1 (en) * 2000-12-22 2006-06-23 Oreal NOVEL C-GLYCOSIDE DERIVATIVES AND USE
US7273852B2 (en) * 2002-06-13 2007-09-25 The Research Foundation Of The City University Of New York Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases

Also Published As

Publication number Publication date
FR2899464A1 (en) 2007-10-12

Similar Documents

Publication Publication Date Title
MA28802B1 (en) THERAPEUTIC USES OF RTP801 INHIBITORS
RS51646B (en) Tricyclic compunds and their use as glucocorticoid receptor modulators
WO2007105058A8 (en) Pyrazole compounds
DK1653807T3 (en) Use of dermal microorganisms
DE602006012166D1 (en) Aqueous pressure-sensitive adhesive composition, pressure-sensitive adhesive tape and wiring harness
BRPI0911688A2 (en) "pyrimidine compounds, compositions and methods of use"
IL197161A (en) Derivatives of 4-(n-azacycloalkyl)anilides, compositions containing the same and uses thereof
HK1122034A1 (en) Azolopyrimidines as inhibitors of cannabinoid 1 activity
CY1113102T1 (en) PHENYLPROPIONAMIDE COMPOUNDS AND THEIR USE
FR2895676B1 (en) COSMETIC COMPOSITION CONTAINING GLAUCIN AND USE THEREOF
FR2958542B1 (en) COSMETIC USE OF ORIDONIN AS SLIMMING AGENT
BRPI0812632A2 (en) of aqueous effluent compounds "
BRPI0909954A2 (en) "diazacarbazoles and methods of use"
BRPI0813202A2 (en) "ABSORBENT ADHESIVE BODY"
JP2006502186A5 (en) Use of β-glucan
FR2899464B1 (en) C-GLYCOSIDE COMPOUND AND USE AS AN ACTIVATOR AND REGULATOR OF CUTANEOUS IMMUNITY
FR2899588B1 (en) USE OF GALACTOSE-DERIVED C-GLYCOSIDE COMPOUND AS AN ACTIVATOR AND REGULATOR OF SKIN IMMUNITY
FR2899467B1 (en) USE OF DERIVATIVE C-GLYCOSIDES AS PROTECTIVE AGENT AND / OR ACTIVATOR OF GAMMA DELTA T LYMPHOCYTES
MA28698B1 (en) SUBSTITUTED DICETOPIPERAZINES AS ANTAGONISTS OF OXYTOCINES
FR2899468B1 (en) USE OF GALACTOSE-DERIVED C-GLYCOSIDES AS PROTECTIVE AND / OR ACTIVATOR AGENT OF GAMMA DELTA TUMMOCYTES
FR2899474B1 (en) USE OF C-GLYCOSIDE COMPOUND DERIVATIVE D- AND L-FUCOSE AS ACTIVATOR AND REGULATOR OF CUTANEOUS IMMINITIS
FR2899463B1 (en) USE OF C-GLYCOSIDE COMPOUND AS AN ACTIVATOR AND REGULATOR OF CUTANEOUS IMMUNITY
FR2899469B1 (en) USE OF D- AND L-FUCOSE DERIVATIVE AS PROTECTIVE AGENT AND / OR ACTIVATOR OF GAMMA DELTA T LYMPHOCYTES
FR2899466B1 (en) USE OF C-GLYCOSIDE COMPOUND ACTIVATING AGENT AND REGULATOR OF SKIN IMMUNITY
FR2899587B1 (en) USE OF LACTOSE-DERIVED C-GLYCOSIDE COMPOUND AS AN ACTIVATOR AND REGULATOR OF SKIN IMMUNITY

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091231